METASTATIC SOFT TISSUE SARCOMA
Clinical trials for METASTATIC SOFT TISSUE SARCOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SOFT TISSUE SARCOMA trials appear
Sign up with your email to follow new studies for METASTATIC SOFT TISSUE SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to outsmart tough cancers
Disease control Recruiting nowThis study is testing whether adding two newer immunotherapy drugs to a standard chemotherapy drug (doxorubicin) can help control advanced soft tissue sarcoma for longer. It will enroll about 65 adults with specific types of this cancer who have not had certain prior treatments. …
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Doctors test supercharged immune cells against tough sarcomas
Disease control Recruiting nowThis early-stage trial is testing a new type of personalized cell therapy for people with advanced soft tissue or bone sarcoma that has spread or come back. Researchers will take a patient's own immune cells, modify them in a lab to better target the cancer, and then infuse them …
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
First patients receive experimental sarcoma drug in groundbreaking trial
Disease control Recruiting nowThis is the first time a new drug called ADCE-D01 is being tested in people. The study aims to find a safe and effective dose for adults with advanced soft tissue sarcoma that has spread or cannot be removed by surgery. Researchers will check how the body handles the drug and see…
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Adcendo ApS • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New Two-Drug attack tested for Tough-to-Treat sarcomas
Disease control Recruiting nowThis study is testing a new treatment approach for people with advanced soft tissue sarcomas, including leiomyosarcoma and dedifferentiated liposarcoma. It aims to find the safest dose and best schedule for combining the drug abemaciclib with chemotherapy (gemcitabine). The main …
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New lung 'Bath' aims to stop Cancer's return after surgery
Disease control Recruiting nowThis study is testing a new, minimally invasive way to deliver chemotherapy directly to the lungs. It aims to kill any tiny, leftover cancer cells after surgery in patients whose sarcoma or colorectal cancer has spread to the lungs. The goal is to prevent the cancer from coming b…
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Roswell Park Cancer Institute • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New Triple-Threat attack on advanced sarcoma begins human testing
Disease control Recruiting nowThis is an early-stage study to test the safety of a new three-drug combination for people with advanced soft tissue sarcoma that has spread. The trial will enroll 18 patients to see if the drugs can be given together safely and to get an early look at whether the treatment helps…
Matched conditions: METASTATIC SOFT TISSUE SARCOMA
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC